Next Article in Journal
Accrual-Monitoring Practices for Various Disease Trials among AACI Member Cancer Centers
Previous Article in Journal
Cerebral Seizures in an Adolescent with Jervell and Lange-Nielsen Syndrome: It May Not Be Epilepsy
 
 
Case Report

Severe Stenosis of Mitral Bioprosthetic Valve Thrombosis in a Patient with HCV-Related Cirrhosis and Duodenal Variceal Bleeding: The Deadly Triad

1
Cardiology Unit, Antonio Cardarelli Hospital, 80131 Naples, Italy
2
Gastroenterology Unit, Antonio Cardarelli Hospital, 80131 Naples, Italy
3
Department of General and Emergency Radiology, Antonio Cardarelli Hospital, 80131 Naples, Italy
4
Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy
5
IRCCS SYNLAB SDN, Via Emanuele Gianturco, 80143 Naples, Italy
6
Chief Medical Officer, Antonio Cardarelli Hospital, 80131 Naples, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editors: Vipul D. Yagnik and Alberto Cordero
Clin. Pract. 2022, 12(5), 686-691; https://doi.org/10.3390/clinpract12050071
Received: 18 June 2022 / Revised: 2 August 2022 / Accepted: 24 August 2022 / Published: 29 August 2022
Bioprosthetic valve thrombosis (BPVT) is considered a relatively rare but life-threatening clinical entity. Thus, there is the need of high clinical suspicion in order to make a timely diagnosis and related appropriate therapeutic interventions. In this regard, the management of BPVT is high risk, whatever the option taken (surgery and/or systemic fibrinolysis). The presence of severe comorbidities—as decompensated cirrhosis—further complicates the clinical decision-making process, calling for a patient-tailored integrated multidisciplinary approach. We report a challenging case of a 45-year-old patient with mitral bioprosthetic valve thrombosis and hepatitis C virus (HCV)-related cirrhosis complicated by active duodenal variceal bleeding. View Full-Text
Keywords: bioprosthetic mitral valve thrombosis; HCV-related cirrhosis; duodenal variceal bleeding bioprosthetic mitral valve thrombosis; HCV-related cirrhosis; duodenal variceal bleeding
Show Figures

Figure 1

MDPI and ACS Style

Cocchia, R.; Chianese, S.; Lombardi, G.; Romano, L.; Capone, V.; Amitrano, L.; Bennato, R.; Ranieri, B.; Russo, G.; Mauro, C.; Bossone, E. Severe Stenosis of Mitral Bioprosthetic Valve Thrombosis in a Patient with HCV-Related Cirrhosis and Duodenal Variceal Bleeding: The Deadly Triad. Clin. Pract. 2022, 12, 686-691. https://doi.org/10.3390/clinpract12050071

AMA Style

Cocchia R, Chianese S, Lombardi G, Romano L, Capone V, Amitrano L, Bennato R, Ranieri B, Russo G, Mauro C, Bossone E. Severe Stenosis of Mitral Bioprosthetic Valve Thrombosis in a Patient with HCV-Related Cirrhosis and Duodenal Variceal Bleeding: The Deadly Triad. Clinics and Practice. 2022; 12(5):686-691. https://doi.org/10.3390/clinpract12050071

Chicago/Turabian Style

Cocchia, Rosangela, Salvatore Chianese, Giovanni Lombardi, Luigia Romano, Valentina Capone, Lucio Amitrano, Raffaele Bennato, Brigida Ranieri, Giuseppe Russo, Ciro Mauro, and Eduardo Bossone. 2022. "Severe Stenosis of Mitral Bioprosthetic Valve Thrombosis in a Patient with HCV-Related Cirrhosis and Duodenal Variceal Bleeding: The Deadly Triad" Clinics and Practice 12, no. 5: 686-691. https://doi.org/10.3390/clinpract12050071

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop